Cargando…
Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken
Adjuvant enhancing mucosal immune response is preferred in controlling many pathogens at the portal of entry. Earlier, we reported that a toll-like-receptor 7 (TLR7) agonist, resiquimod (R-848), stimulated the systemic immunity when adjuvanted with the inactivated Newcastle disease virus vaccine in...
Autores principales: | Matoo, Javaid Jeelani, Bashir, Khalid, Kumar, Ajay, Krishnaswamy, Narayanan, Dey, Sohini, Chellappa, Madhan Mohan, Ramakrishnan, Saravanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127065/ https://www.ncbi.nlm.nih.gov/pubmed/29635053 http://dx.doi.org/10.1016/j.micpath.2018.04.012 |
Ejemplares similares
-
Evaluation of a Lipopolysaccharide and Resiquimod Combination as an Adjuvant with Inactivated Newcastle Disease Virus Vaccine in Chickens
por: Sharma, Bal Krishnan, et al.
Publicado: (2022) -
Combination of TLR2 and TLR3 agonists derepress infectious bursal disease virus vaccine-induced immunosuppression in the chicken
por: Bashir, Khalid, et al.
Publicado: (2019) -
Newcastle Disease Virus Vectored Bivalent Vaccine against Virulent Infectious Bursal Disease and Newcastle Disease of Chickens
por: Dey, Sohini, et al.
Publicado: (2017) -
Newcastle Disease Virus Vectored Chicken Infectious Anaemia Vaccine Induces Robust Immune Response in Chickens
por: Chellappa, Madhan Mohan, et al.
Publicado: (2021) -
Avian Infectious Bronchitis Virus
por: Ramakrishnan, Saravanan, et al.
Publicado: (2019)